The Link Between Diabetes and Your Gallbladder’s Health

People with type 2 diabetes develop gallstones at roughly two to three times the rate of people without the disease, and the connection runs deeper than a shared risk factor like obesity. Insulin resistance itself changes the chemical makeup of bile and weakens the gallbladder’s ability to contract, creating ideal conditions for stones to form. What makes this relationship especially tricky is that some of the very medications used to manage diabetes can independently raise gallbladder risk, while nerve damage from poorly controlled blood sugar can mask the symptoms of gallbladder trouble until it becomes a surgical emergency.

How Common Are Gallstones in People With Diabetes

The numbers vary by population, but the pattern is consistent across studies on multiple continents. In a case-control study from Libya, about 40% of people with type 2 diabetes had gallbladder stones, compared with roughly 18% of matched non-diabetic controls, making the rate more than twice as high in the diabetic group. Women with diabetes were hit hardest, with a prevalence of 47% compared with 26% in diabetic men.¹ A similar study from North India found gallstones in about 18% of diabetic patients versus around 6% in non-diabetic controls, with prevalence peaking in the sixth decade of life.²

These observational findings could be partly explained by the fact that diabetes and gallstones share risk factors like obesity. A Mendelian randomization study, which uses genetic variation to tease apart cause from correlation, found that a genetic predisposition to type 2 diabetes was independently associated with a higher risk of gallstones even after accounting for body mass index. Genetic liability to higher BMI and larger waist circumference also independently raised gallstone risk.³ In other words, diabetes adds its own layer of risk on top of whatever body weight contributes.

How Insulin Resistance Changes Bile

Your gallbladder stores bile, a digestive fluid that the liver produces. Bile is a careful mixture of cholesterol, bile acids, and other components. When the balance tips and there is too much cholesterol relative to everything else, crystals form, and those crystals can grow into stones. Insulin resistance pushes that balance in the wrong direction through several mechanisms at once.

When the liver becomes resistant to insulin, a chain of events increases the amount of cholesterol the liver dumps into bile. Research in animal models has shown that insulin resistance ramps up the activity of cholesterol transport proteins in the liver, while simultaneously reducing enzymes that would convert some of that cholesterol into bile acids. The result is bile that is supersaturated with cholesterol and deficient in the bile acids that would normally keep that cholesterol dissolved.⁴ The high insulin levels that accompany insulin resistance compound the problem by further boosting hepatic cholesterol secretion and impairing the gallbladder’s ability to squeeze bile out effectively.⁵

So the two essential ingredients for gallstone formation, cholesterol-heavy bile and a gallbladder that does not empty well, are both direct consequences of the metabolic state that defines type 2 diabetes.

Gallbladder Motility and Diabetic Nerve Damage

The gallbladder contracts after meals in response to hormonal signals, mainly cholecystokinin (CCK). In people with diabetes, the gallbladder tends to hold a larger resting volume and contract less forcefully. Ultrasound studies have shown that gallbladder volume is significantly larger in diabetics than in controls, and that motility is markedly worse in diabetics who also have autonomic neuropathy, the type of nerve damage that affects involuntary functions like digestion, heart rate, and bladder control.⁶ The severity of the gallbladder’s contractile problem correlates with how advanced the autonomic nerve damage is.⁷

A sluggish gallbladder means bile sits around longer, giving cholesterol crystals more time to clump together. This stasis is one reason why gallstone risk climbs as diabetes progresses and nerve damage accumulates. It also explains why people with well-controlled, shorter-duration diabetes may face a substantially lower risk than those who have lived with poorly controlled blood sugar for years.

The Lipid Connection

Diabetes rarely travels alone. High triglycerides and low HDL cholesterol are common companions, and both appear to influence gallbladder health. A prospective study found that fasting insulin levels, low HDL, elevated triglycerides, and (in women) hormone replacement therapy were all independently associated with a higher risk of being hospitalized for gallbladder disease.⁸ High triglycerides may impair gallbladder motility even beyond what obesity alone accounts for.⁹

For someone managing diabetes, this means that lipid control is not just about cardiovascular protection. Bringing triglycerides down and HDL up may also reduce the likelihood of gallbladder trouble, though no randomized trial has directly tested that idea.

Diabetes Medications That Affect Gallbladder Risk

This is one of the more underappreciated aspects of the diabetes-gallbladder relationship. The incretin-based drugs that have become mainstays of type 2 diabetes treatment, including GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, exenatide) and DPP-4 inhibitors (sitagliptin, saxagliptin, and others), have measurable effects on the gallbladder.

GLP-1 receptor agonists suppress the release of CCK after meals, the same hormone the gallbladder needs to contract properly. With less CCK signaling, the gallbladder does not empty as completely, creating bile stasis that favors stone formation.¹⁰¹¹ A large cohort study found that by two years, GLP-1 receptor agonist use was associated with about a 44% higher rate of gallstones compared with other diabetes treatments, and by three years, rates of gallbladder inflammation and gallbladder removal surgery were also significantly elevated. Semaglutide and dulaglutide drove most of the risk, while liraglutide and exenatide did not show a significant increase.¹²

DPP-4 inhibitors carry a similar concern. A systematic review and network meta-analysis of randomized trials found that DPP-4 inhibitors were associated with about a 22% higher odds of gallbladder or biliary disease overall, and a 43% higher odds of gallbladder inflammation specifically, compared with placebo or non-incretin drugs.¹³ A separate population-based cohort study estimated about a 46% increased risk, though in absolute terms the extra cases were modest, around one to two additional events per thousand person-years of treatment.¹⁴

SGLT2 inhibitors, by contrast, may move the needle in the opposite direction. A retrospective cohort study found that SGLT2 inhibitor use was associated with about a 40% lower risk of biliary disease, an effect that grew stronger beyond 24 months of use. Patients on SGLT2 inhibitors also showed higher HDL cholesterol and lower total bile acid and bilirubin levels, suggesting a favorable shift in bile composition.¹⁵ None of this means you should switch medications on your own, but it is worth discussing with your doctor if you have known gallbladder problems or a history of gallstones.

When Gallbladder Attacks Look Different in Diabetics

Gallbladder inflammation normally announces itself with sharp pain in the upper right abdomen, tenderness, fever, and elevated white blood cell counts. People with diabetes, especially those with autonomic neuropathy, can present without these classic warning signs. A case report of gangrenous cholecystitis in a diabetic patient documented the absence of both the expected right-upper-quadrant pain and the typical jump in white blood cells, which delayed the diagnosis and pushed back surgery.¹⁶ Given that up to half of people with diabetes eventually develop some form of neuropathy, these atypical presentations are not rare oddities. They are a real clinical trap.

The practical takeaway is that vague abdominal discomfort, unexplained nausea, or subtle changes in digestion in someone with longstanding diabetes should prompt a lower threshold for imaging. Waiting for the textbook gallbladder attack can mean the difference between a routine procedure and an emergency one.

Surgical Outcomes for Diabetic Patients

There is real nuance here, and the evidence is not perfectly consistent. An older study from the 1980s found that complication and death rates after gallbladder surgery were essentially the same in diabetic and non-diabetic patients, concluding that diabetes alone did not worsen prognosis.¹⁷ But more recent data, particularly from emergency settings, tells a different story. A study of emergency cholecystectomy found that diabetic patients had a mortality rate of about 4.4% versus 1.4% for non-diabetics, with significantly higher rates of gallbladder perforation before surgery and more cardiovascular and kidney complications afterward. Patients on insulin faced substantially worse outcomes than those managed with oral medications alone.¹⁸

Reviews of laparoscopic cholecystectomy have also flagged higher rates of conversion to open surgery and worse intraoperative outcomes in diabetics, linked to vascular stiffness that causes prolonged bleeding and impaired wound healing from chronic high blood sugar.¹⁹ The severity of cholecystitis itself has been reported as greater in diabetics in at least one study²⁰, though another did not find a significant association between diabetes and cholecystitis severity.²¹

The gap between elective and emergency outcomes is probably the most important takeaway. A planned cholecystectomy in a diabetic patient whose blood sugar is well controlled carries manageable risk. An emergency operation after a delayed or missed diagnosis carries dramatically higher risk. This loops back to the diagnostic challenges: diabetic neuropathy masks symptoms, symptoms get ignored, and by the time the problem is obvious the gallbladder is perforated or gangrenous.

Does Type 1 Diabetes Carry the Same Risk

Most of the research on diabetes and gallstones focuses on type 2, where insulin resistance is the central driver. The evidence for type 1 diabetes is thinner and more reassuring, at least in younger patients. A study of 105 children with type 1 diabetes, followed for up to eight years from diagnosis, found zero cases of gallstones or biliary sludge on ultrasound.²² That does not mean type 1 diabetes never increases gallstone risk over a lifetime, but it suggests the mechanism is fundamentally different. Without the insulin resistance and metabolic syndrome that characterize type 2, the bile-composition and motility changes that drive stone formation are much less pronounced, at least in the short and medium term.

Adults with type 1 diabetes who develop complications like autonomic neuropathy over decades might still face elevated gallbladder risk through the motility pathway. But the aggressive, insulin-resistance-driven gallstone formation seen in type 2 is not a major feature of type 1.

Gallstones, Fatty Liver, and the Metabolic Web

Type 2 diabetes, gallstone disease, and nonalcoholic fatty liver disease cluster together so frequently that separating their individual contributions is challenging. A cross-sectional study found that gallstone disease and prior gallbladder removal were both associated with fatty liver in type 2 diabetes patients. People with fatty liver had a higher proportion of cholecystectomies and a lower proportion of silent, asymptomatic gallstones, suggesting that the combination of fatty liver and diabetes may push gallstones toward becoming symptomatic more often.²³

Emerging research on the gut microbiome adds another layer. Hyperglycemia and insulin resistance are associated with shifts in the gut bacterial community that alter how bile acids are processed. These microbial changes favor a more hydrophobic bile acid profile, which can disrupt signaling pathways that normally regulate bile acid production and gallbladder contraction. The result is a feedback loop: diabetes changes the gut bacteria, the changed bacteria produce bile acids that promote stone formation and metabolic inflammation, and that inflammation worsens insulin resistance.²⁴

Rapid Weight Loss and Gallstone Risk in Diabetes

Many people with type 2 diabetes pursue significant weight loss through bariatric surgery or aggressive dietary changes, and rapid weight loss is itself a well-known gallstone trigger. In people with obesity, the risk of gallstone formation is already roughly five times that of the general population. After bariatric surgery, the incidence of new gallstones ranges from about 10% to 38%, depending on the procedure and follow-up period.²⁵ When the person losing that weight also has insulin-resistant, cholesterol-heavy bile and a sluggish gallbladder from diabetes, the risk compounds. Ursodeoxycholic acid is commonly used to prevent gallstones during rapid weight-loss periods, and this is something worth discussing with your surgical or weight-management team before starting any aggressive intervention.

Insulin Resistance During Pregnancy

Pregnancy itself promotes gallstone formation through hormonal changes and slowed gallbladder emptying. When gestational diabetes or pre-existing insulin resistance is added to the mix, the risk is amplified. A study of pregnant women found that insulin resistance was significantly associated with new gallstone formation during pregnancy, even after adjusting for pre-pregnancy BMI, HDL cholesterol, and physical activity.²⁶ For women with gestational diabetes or known insulin resistance, awareness of this risk matters because biliary symptoms during pregnancy can be difficult to distinguish from other pregnancy-related abdominal complaints, and gallbladder surgery during pregnancy carries its own set of considerations.

What Happens to Metabolism After the Gallbladder Comes Out

Gallbladder removal is the most common treatment for symptomatic gallstones, and it is generally safe and effective. But for people with diabetes, there is an interesting metabolic twist. Bile acids do not just digest fat; they also act as signaling molecules that influence blood sugar regulation. Removing the gallbladder changes how bile acids flow into the intestine, from being released in concentrated bursts after meals to a continuous trickle.

A prospective study of type 2 diabetes patients who underwent gallbladder removal found that total bile acid levels rose after surgery and that fasting blood glucose, hemoglobin A1c, and a standard measure of insulin resistance all decreased. Cholesterol markers improved too, with total and LDL cholesterol going down while HDL went up.²⁷ The bile acid receptor signaling pathways through which this may work, particularly FXR and TGR5, are involved in regulating glucose metabolism and stimulating insulin secretion.²⁸²⁹

This does not mean gallbladder removal is a treatment for diabetes, and any metabolic improvement from the procedure is modest and likely intertwined with other changes like reduced inflammation and altered eating habits after surgery. But it does mean that the relationship between diabetes and the gallbladder runs in both directions. Diabetes promotes gallstones, and the treatment of those gallstones may, in a small way, alter the metabolic landscape of the diabetes itself.